These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8827214

  • 1. Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.
    Myagkikh M, Alipanah S, Markham PD, Tartaglia J, Paoletti E, Gallo RC, Franchini G, Robert-Guroff M.
    AIDS Res Hum Retroviruses; 1996 Jul 20; 12(11):985-92. PubMed ID: 8827214
    [Abstract] [Full Text] [Related]

  • 2. Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.
    Patterson LJ, Peng B, Abimiku AG, Aldrich K, Murty L, Markham PD, Kalyanaraman VS, Alvord WG, Tartaglia J, Franchini G, Robert-Guroff M.
    AIDS; 2000 Nov 10; 14(16):2445-55. PubMed ID: 11101054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
    García-Arriaza J, Perdiguero B, Heeney J, Seaman M, Montefiori DC, Labranche C, Yates NL, Shen X, Tomaras GD, Ferrari G, Foulds KE, McDermott A, Kao SF, Roederer M, Hawkins N, Self S, Yao J, Farrell P, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo A, Weiss D, Lee C, Kibler K, Jacobs B, Asbach B, Wagner R, Ding S, Pantaleo G, Esteban M.
    J Virol; 2015 Aug 10; 89(16):8525-39. PubMed ID: 26041302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.
    Abimiku AG, Franchini G, Tartaglia J, Aldrich K, Myagkikh M, Markham PD, Chong P, Klein M, Kieny MP, Paoletti E.
    Nat Med; 1995 Apr 10; 1(4):321-9. PubMed ID: 7585061
    [Abstract] [Full Text] [Related]

  • 7. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C, Coulibaly C, Petry H, Voss G, Dittmer U, Bodemer W, Makoschey B, Jurkiewicz E, Lüke W, Hunsmann G.
    AIDS Res Hum Retroviruses; 1994 Apr 10; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
    Hel Z, Nacsa J, Tsai WP, Thornton A, Giuliani L, Tartaglia J, Franchini G.
    Virology; 2002 Dec 05; 304(1):125-34. PubMed ID: 12490410
    [Abstract] [Full Text] [Related]

  • 11. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M, Carter L, Venzon DJ, Romano J, Markham PD, Limbach K, Tartaglia J, Paoletti E, Benson J, Franchini G, Robert-Guroff M.
    AIDS Res Hum Retroviruses; 1999 Mar 20; 15(5):461-70. PubMed ID: 10195756
    [Abstract] [Full Text] [Related]

  • 12. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q, Li Y, Luo Z, Yang G, Liu Y, Liu Y, Sun M, Dai J, Li Q, Qin C, Shao Y.
    AIDS; 2015 Mar 27; 29(6):649-58. PubMed ID: 25849828
    [Abstract] [Full Text] [Related]

  • 13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.
    J Virol; 2005 Oct 27; 79(19):12321-31. PubMed ID: 16160159
    [Abstract] [Full Text] [Related]

  • 14. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
    Gómez CE, Nájera JL, Jiménez EP, Jiménez V, Wagner R, Graf M, Frachette MJ, Liljeström P, Pantaleo G, Esteban M.
    Vaccine; 2007 Apr 12; 25(15):2863-85. PubMed ID: 17113200
    [Abstract] [Full Text] [Related]

  • 15. Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.
    Perdiguero B, Asbach B, Gómez CE, Köstler J, Barnett SW, Koutsoukos M, Weiss DE, Cristillo AD, Foulds KE, Roederer M, Montefiori DC, Yates NL, Ferrari G, Shen X, Sawant S, Tomaras GD, Sato A, Fulp WJ, Gottardo R, Ding S, Heeney JL, Pantaleo G, Esteban M, Wagner R.
    Front Immunol; 2022 Apr 12; 13():939627. PubMed ID: 35935978
    [Abstract] [Full Text] [Related]

  • 16. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE, Nájera JL, Jiménez V, Bieler K, Wild J, Kostic L, Heidari S, Chen M, Frachette MJ, Pantaleo G, Wolf H, Liljeström P, Wagner R, Esteban M.
    Vaccine; 2007 Mar 01; 25(11):1969-92. PubMed ID: 17224219
    [Abstract] [Full Text] [Related]

  • 17. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.
    Virology; 2001 Jan 05; 279(1):241-56. PubMed ID: 11145906
    [Abstract] [Full Text] [Related]

  • 18. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
    Ferrantelli F, Maggiorella MT, Schiavoni I, Sernicola L, Olivieri E, Farcomeni S, Pavone-Cossut MR, Moretti S, Belli R, Collacchi B, Srivastava IK, Titti F, Cafaro A, Barnett SW, Ensoli B.
    Vaccine; 2011 Apr 05; 29(16):2918-32. PubMed ID: 21338681
    [Abstract] [Full Text] [Related]

  • 19. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E, Kurane I, Mason PW, Shope RE, Ennis FA.
    Virology; 1997 Jan 20; 227(2):353-60. PubMed ID: 9018134
    [Abstract] [Full Text] [Related]

  • 20. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP, Pierce CC, Watson AJ, Robertson MN, Montefiori DC, Kuller L, Richardson BA, Bradshaw JD, Munn RJ, Hu SL, Greenberg PD, Benveniste RE, Haigwood NL.
    AIDS Res Hum Retroviruses; 2004 Apr 20; 20(4):425-34. PubMed ID: 15157361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.